Akebia Therapeutics Inc. (AKBA)’s debt-to-equity and long-term debt/equity ratios
As of close of business last night, Akebia Therapeutics Inc.’s stock clocked out at $1.60, down -1.23% from its previous closing price of $1.62. In other words, the price has decreased by -$0.0200 from its previous closing price. On the day, 2035943 shares were traded. AKBA stock price reached its highest trading level at $1.6550 […]
There Is Still Room For Akebia Therapeutics Inc. (AKBA) to Improve Its Value – Let’s Wait for Clarity
The price of Akebia Therapeutics Inc. (NASDAQ: AKBA) closed at $1.54 in the last session, down -6.10% from day before closing price of $1.64. In other words, the price has decreased by -$0.1000 from its previous closing price. On the day, 2496452 shares were traded. AKBA stock price reached its highest trading level at $1.6800 […]
Analysts predict EPS of -$0.04 for Akebia Therapeutics Inc. (AKBA)’s current quarter
After finishing at $1.39 in the prior trading day, Akebia Therapeutics Inc. (NASDAQ: AKBA) closed at $1.35, down -2.88%. In other words, the price has decreased by -$0.0400 from its previous closing price. On the day, 3039679 shares were traded. AKBA stock price reached its highest trading level at $1.4000 during the session, while it […]
